Mechanisms regulating fetal membrane and neutrophil responses to infection
调节胎膜和中性粒细胞对感染反应的机制
基本信息
- 批准号:10876528
- 负责人:
- 金额:$ 40.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-03 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acetylmuramyl-Alanyl-IsoglutamineAgonistAllopurinolBacteriaBacterial InfectionsCellsChemotactic FactorsCommunicationComplexDataExposure toFamilyFetal MembranesFetusGrantHumanIL8 geneImmuneIn VitroInfectionInflammasomeInflammationInflammatoryInflammatory ResponseLipopolysaccharidesMaternal-Fetal ExchangeMediatingMediatorMicroRNAsModelingMusNatureNeutrophil ActivationNeutrophil InfiltrationOutcomePathologicPathologyPattern recognition receptorPeptidoglycanPlayPregnancyPregnancy ComplicationsPremature BirthProcessProductionRegulationRiskRisk FactorsRoleSignal PathwaySignal TransductionSiteSourceTLR2 geneTLR4 geneTLR7 geneTLR8 geneTestingTissue membraneToll-like receptorsUric AcidWomanXanthine Oxidasechemokinecytokineexosomeextracellularin vitro testingin vivoinflammatory milieuinhibitorintraamniotic infectionmouse modelneutrophilnovelprematurereceptorresponsesensortherapeutic targettissue injuryxanthine oxidase inhibitor
项目摘要
Summary/Abstract
Chorioamnionitis - inflammation of the fetal membranes (FM) - is characterized by neutrophil infiltration and is
a major risk factor for preterm birth. Even in the absence of prematurity, chorioamnionitis can be detrimental to
the fetus. Despite a strong association between bacterial infection, chorioamnionitis, and preterm birth, the
mechanisms involved are not fully understood. Through expression of the innate immune pattern recognition
receptors (PRR), Toll-like receptors (TLRs) and Nod-like receptors (NLRs), FMs have strategies to evade and
protect against infection. However, depending upon the nature of signaling and regulation, these protective
immune mechanisms may create an inflammatory milieu that can contribute to pathology. In particular, IL-8 is a
major neutrophil chemoattractant and inflammasome-mediated IL-1b is a major inducer of tissue injury and
mediator of preterm birth. We have found that the chorionic compartment is the primary site of FM IL-8 and IL-
1b production in response to bacterial lipopolysaccharide (LPS), peptidoglycan (PDG), and muramyl dipeptide
(MDP) which activate TLR4, TLR2, and Nod2, respectively. While TLRs and NLRs can directly activate
signaling pathways leading to inflammatory cytokine/chemokine production, there is the potential for far more
complex modulation, regulation, and fine-tuning of these processes and the type of responses generated,
particularly for IL-1b. This grant focusses on the requirement of two or more PRRs to be activated sequentially
in FMs exposed to bacterial triggers via novel intermediates. A non-classical family of microRNAs (miRs)
activate the ssRNA sensors, TLR7 and TLR8, to elicit an inflammatory response. These miRs can also be
carried in exosomes and delivered to TLR7 or TLR8 in target cells. Our preliminary data supports the concept
that TLR8-activating miR-146a-3p may acts as a novel intermediate signal that drives FM chemotactic and
inflammatory responses to bacterial TLR and NLR agonists. We also have preliminary data demonstrating that
FM-derived exosomes containing TLR8-activating miRs trigger neutrophil activation and release of neutrophil
extracellular traps. Finally, we found that FM tissue and circulating exosomal TLR8-activating miR-146a-3p is
elevated in women with preterm birth. Based on this, our central hypothesis is that TLR8-activating miRs
mediate FM chemotactic IL-8 and inflammasome-mediated inflammatory IL-1b in response to bacterial
triggers, and through their release and delivery via exosomes active maternal neutrophils. This leads
to inflammation at the maternal-fetal interface, increasing the risk for chorioamnionitis. To test this, our
specific aims are to determine if:
Aim 1. TLR8-activating miRs mediate a FM chemotactic IL-8 response after exposure to bacterial triggers.
Aim 2. TLR8-activating miRs contribute to FM inflammasome activation and inflammatory IL-1b production.
Aim 3. FM exosomes containing TLR8-activating miRs induce neutrophil activation.
摘要/摘要
绒毛膜羊膜炎——胎膜炎症(FM)——以中性粒细胞浸润为特征,
早产的主要危险因素。即使没有早产,绒毛膜羊膜炎也可能对胎儿造成损害。
胎儿。尽管细菌感染、绒毛膜羊膜炎和早产之间存在密切关联,
所涉及的机制尚不完全清楚。通过表达先天免疫模式识别
受体(PRR)、Toll 样受体(TLR)和 Nod 样受体(NLR),FM 具有逃避和防御策略
防止感染。然而,根据信号传导和调节的性质,这些保护性
免疫机制可能会产生导致病理的炎症环境。特别地,IL-8是
主要的中性粒细胞趋化剂和炎症小体介导的 IL-1b 是组织损伤和
早产的中介者。我们发现绒毛膜室是 FM IL-8 和 IL-的主要位点。
1b 响应细菌脂多糖 (LPS)、肽聚糖 (PDG) 和胞壁酰二肽而产生
(MDP) 分别激活 TLR4、TLR2 和 Nod2。而TLR和NLR可以直接激活
导致炎症细胞因子/趋化因子产生的信号通路,还有更多的潜力
这些过程的复杂调制、调节和微调以及生成的响应类型,
特别是对于 IL-1b。该补助金重点关注两个或多个 PRR 依次激活的要求
在通过新型中间体暴露于细菌触发物的 FM 中。非经典的 microRNA (miR) 家族
激活 ssRNA 传感器 TLR7 和 TLR8,引发炎症反应。这些 miR 也可以
携带在外泌体中并递送至靶细胞中的TLR7或TLR8。我们的初步数据支持这个概念
TLR8 激活 miR-146a-3p 可能作为一种新型中间信号驱动 FM 趋化和
对细菌 TLR 和 NLR 激动剂的炎症反应。我们还有初步数据表明
含有 TLR8 激活 miR 的 FM 衍生外泌体可触发中性粒细胞激活和中性粒细胞释放
细胞外陷阱。最后,我们发现 FM 组织和循环外泌体 TLR8 激活 miR-146a-3p 是
早产女性中升高。基于此,我们的中心假设是 TLR8 激活 miR
介导 FM 趋化性 IL-8 和炎症小体介导的炎症性 IL-1b 对细菌的反应
触发因素,并通过外泌体释放和递送活跃的母体中性粒细胞。这导致
母胎界面炎症,增加绒毛膜羊膜炎的风险。为了测试这一点,我们的
具体目标是确定是否:
目标 1. TLR8 激活 miR 在暴露于细菌触发物后介导 FM 趋化性 IL-8 反应。
目标 2. TLR8 激活 miR 有助于 FM 炎症小体激活和炎症 IL-1b 产生。
目标 3. 含有 TLR8 激活 miR 的 FM 外泌体诱导中性粒细胞激活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vikki M Abrahams其他文献
Vikki M Abrahams的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vikki M Abrahams', 18)}}的其他基金
Role of Hofbauer Cells in Fetal Infection/Inflammation
霍夫鲍尔细胞在胎儿感染/炎症中的作用
- 批准号:
10218030 - 财政年份:2017
- 资助金额:
$ 40.4万 - 项目类别:
Role of Hofbauer Cells in Fetal Infection/Inflammation
霍夫鲍尔细胞在胎儿感染/炎症中的作用
- 批准号:
9750631 - 财政年份:2017
- 资助金额:
$ 40.4万 - 项目类别:
Role of Hofbauer Cells in Fetal Infection/Inflammation
霍夫鲍尔细胞在胎儿感染/炎症中的作用
- 批准号:
9980782 - 财政年份:2017
- 资助金额:
$ 40.4万 - 项目类别:
Role of Hofbauer Cells in Fetal Infection/Inflammation
霍夫鲍尔细胞在胎儿感染/炎症中的作用
- 批准号:
9323669 - 财政年份:2017
- 资助金额:
$ 40.4万 - 项目类别:
Mechanisms regulating fetal membrane and neutrophil responses to polymicrobial infection
调节胎膜和中性粒细胞对多种微生物感染反应的机制
- 批准号:
9302657 - 财政年份:2016
- 资助金额:
$ 40.4万 - 项目类别:
Innate Immune Responses of Trophoblasts in Pregnancy
妊娠期滋养层细胞的先天免疫反应
- 批准号:
8037255 - 财政年份:2005
- 资助金额:
$ 40.4万 - 项目类别:
Innate Immune Responses of Trophoblasts in Pregnancy
妊娠期滋养层细胞的先天免疫反应
- 批准号:
7390377 - 财政年份:2005
- 资助金额:
$ 40.4万 - 项目类别:
Innate Immune Responses of Trophoblasts in Pregnancy
妊娠期滋养层细胞的先天免疫反应
- 批准号:
7616542 - 财政年份:2005
- 资助金额:
$ 40.4万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 40.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 40.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 40.4万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 40.4万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 40.4万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 40.4万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 40.4万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 40.4万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 40.4万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 40.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




